We have seen AI software used by doctors to detect brain cancer, kidney disease, and other types of cancers in the past. Researchers from IBM and Michael J. Researchers from IBM and Michael J. Fox Foundation (MJFF), have developed a program that predicts how a Parkinsons patient's symptoms will develop in terms of severity and timing. The software, according to The Lancet Digital Health journal could change the way doctors treat patients with Parkinson's disease by helping them predict the progression of the disease.Our goal is to utilize AI to assist with clinical trial design and patient management. IBM stated that these goals are important as Parkinson's patients can experience a wide range of motor and nonmotor symptoms, despite their prevalence.Without the Parkinsons Progression Markers Initiative (a study that Michael J. The Fox Foundation sponsored the research. The dataset, which contains information on over 1,400 people, is described by IBM as the largest and most robust longitudinal Parkinsons patient data. It also allows IBM's AI model to identify complex progression and symptom patterns.Parkinson's disease is estimated to affect more than 6,000,000 people worldwide. There is currently no cure. IBM Research and MJFF will continue to work on the AI model. They hope to improve the model in the future by providing better characterizations of each stage of the disease.
